Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
AadNaCl 600mg Slow tablets
0902012L0BFAAAJ
|
AadNaCl | Sodium chloride | Nutrition and Blood | No data available |
|
AadPhos effervescent tablets
090502100BPBEAA
|
Proprietary compound preparation BNF 0905021 | Other phosphate supplement preparations | Nutrition and Blood | No data available |
|
AadZinc 125mg effervescent tablets
0905041R0BDAAAB
|
AadZinc (Monohydrate) | Zinc sulfate monohydrate | Nutrition and Blood | No data available |
|
AAnDD capsules
0906011D0BIAAAH
|
AAnDD | Vitamin A | Nutrition and Blood | No data available |
|
Aargin 500mg/5ml oral solution
091101000BBVAEL
|
Proprietary compound preparation BNF 0911010 | Other amino acidandnutritional agent preparations | Nutrition and Blood | No data available |
|
AascorbDose 100mg tablets
0906031C0CKABAG
|
AascorbDose | Ascorbic acid | Nutrition and Blood | No data available |
|
AascorbDose 200mg tablets
0906031C0CKACAH
|
AascorbDose | Ascorbic acid | Nutrition and Blood | No data available |
|
AascorbDose 500mg tablets
0906031C0CKADAI
|
AascorbDose | Ascorbic acid | Nutrition and Blood | No data available |
|
Abacavir 20mg/ml oral solution sugar free
0503010E0AAABAB
|
Abacavir | Abacavir | Infections | No data available |
|
Abacavir 300mg / Lamivudine 150mg / Zidovudine 300mg tablets
0503010F0AAAAAA
|
Abacavir/lamivudine/zidovudine | Abacavir/lamivudine/zidovudine | Infections | No data available |
|
Abatacept 125mg/1ml inj pre-filled syringes
1001030V0AAABAB
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abatacept 250mg powder for solution for infusion vials
1001030V0AAAAAA
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abatacept 50mg/0.4ml inj pre-filled syringes
1001030V0AAAEAE
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abatacept 87.5mg/0.7ml inj pre-filled syringes
1001030V0AAADAD
|
Abatacept | Abatacept | Musculoskeletal and Joint Diseases | No data available |
|
Abciximab 10mg/5ml solution for injection vials
0209000W0AAAAAA
|
Abciximab | Abciximab | Cardiovascular System | No data available |
|
Abdine Cold Relief Powder 650mg oral powder sachets
0407010H0CRAADM
|
Abdine | Paracetamol | Central Nervous System | No data available |
|
Abdominal and Umbilical hernia binder 685/2XL
23305951197
|
Abdominal and Umbilical hernia binder 685/2XL | Belts | Stoma Appliances | No data available |
|
Abdominal and Umbilical hernia binder 685/3XL
23305951198
|
Abdominal and Umbilical hernia binder 685/3XL | Belts | Stoma Appliances | No data available |
|
Abdominal and Umbilical hernia binder 685/L
23305951195
|
Abdominal and Umbilical hernia binder 685/L | Belts | Stoma Appliances | No data available |
|
Abdominal and Umbilical hernia binder 685/M
23305951194
|
Abdominal and Umbilical hernia binder 685/M | Belts | Stoma Appliances | No data available |
|
Abdominal and Umbilical hernia binder 685/S
23305951193
|
Abdominal and Umbilical hernia binder 685/S | Belts | Stoma Appliances | No data available |
|
Abdominal and Umbilical hernia binder 685/XL
23305951196
|
Abdominal and Umbilical hernia binder 685/XL | Belts | Stoma Appliances | No data available |
|
Abemaciclib 100mg tablets
0801050CLAAAAAA
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abemaciclib 150mg tablets
0801050CLAAABAB
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
|
Abemaciclib 50mg tablets
0801050CLAAACAC
|
Abemaciclib | Abemaciclib | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.